Bovine Respiratory Disease Treatment Market - Global Industry
Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024
Global Bovine Respiratory Disease Treatment Market: Overview
Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination
of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and
environmental factors. The major factor leading to bovine respiratory diseases are host factors,
environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites.
However, due to increasing consumption of milk and beef products, the need for bovine respiratory
disease treatment has increased across the globe.
Moreover, according to the World Bank Group (2016), global human population is estimated to be 7.4
billion in 2016 and is growing at a rate of 1.8% per year. Hence, demand for beef has increased due
to rising population and increasing disposable income across the world. The rising demand for high
quality bovine derived products is influencing the bovine respiratory disease treatment market. Despite
of innovations in veterinary medicines and advancement in technology, bovine respiratory disease is
the leading cause to impact negatively on both the dairy and beef industries due to calf mortality,
additional labor cost and treatment expenses. Moreover, bovine respiratory disease affects adversely
on reproductive performance, growth and longevity of cattle. Hence, prevention and treatment of
bovine respiratory disease have become important to decrease the impact on animal production and
the beef industry. Therefore, the bovine respiratory disease treatment market is anticipated to witness
significant growth in terms of revenue during the forecast period.
This 165 page report gives readers a comprehensive overview of the Bovine Respiratory Disease
Treatment market Browse through 12 data tables and 25 figures to unlock the hidden opportunities in
this market.
http://www.transparencymarketresearch.com/bovine-respiratory-disease-treatment-market.html
Global Bovine Respiratory Disease Treatment Market: Segmentation
In terms of treatment type, the bovine respiratory disease treatment market has been categorized into
vaccines, antibiotics, NSAIDs, and immunomodulators. Causative agents such as viruses leading to
bovine respiratory disease have no direct treatment. Hence, vaccination is the preferred choice of
preventive action against the disease. This increase market potential for vaccines. However, virus
infected cattle is exposed to bacteria, parasites, and various other factors. Therefore, antibiotics are
the preferred choice of treatment for bovine respiratory diseases. Effective treatment and significant
demand has increased the scope for antibiotics in the bovine respiratory disease treatment market.
However, according to NCBI report, combination treatment with anti-inflammatory drugs such as
NSAIDs has better results over the monotherapy of antibiotics. This has led to increase in usage of
NSAIDs in bovine respiratory disease treatment. Bovine respiratory disease is generally treated with